CUTANEOUS MELANOMA, STAGE III
Clinical trials for CUTANEOUS MELANOMA, STAGE III explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS MELANOMA, STAGE III trials appear
Sign up with your email to follow new studies for CUTANEOUS MELANOMA, STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Less surgery may be just as good for advanced melanoma after immunotherapy
Disease control Recruiting nowThis study tests whether removing only the largest affected lymph node (instead of all nearby lymph nodes) after 6 weeks of standard immunotherapy works just as well for stage III melanoma. About 1500 adults with stage IIIB-D melanoma will be randomly assigned to one of the two s…
Matched conditions: CUTANEOUS MELANOMA, STAGE III
Phase: NA • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New Shot-in-Tumor combo aims to beat melanoma before surgery
Disease control Recruiting nowThis phase 2 trial tests injecting two immunotherapy drugs (ipilimumab and nivolumab) directly into melanoma tumors before surgical removal. The goal is to shrink or eliminate the cancer while reducing the severe side effects that can occur when these drugs are given through a ve…
Matched conditions: CUTANEOUS MELANOMA, STAGE III
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New study tracks hidden side effects of melanoma immunotherapy
Knowledge-focused Recruiting nowThis study follows 300 adults with advanced melanoma who are receiving immune checkpoint inhibitors. Researchers will collect blood samples, quality-of-life surveys, and medical records to track symptoms over time. The goal is to identify patterns and risk factors for worse sympt…
Matched conditions: CUTANEOUS MELANOMA, STAGE III
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC